Article | September 13, 2023
OPDP is Back Sending Untitled Letters after a Yearlong Hiatus
Read More
Article | August 22, 2023
Panel Session Recap: Navigating the M&A Waters of FDA-Regulated Companies
Read More
Article | August 07, 2023
FDA Regulatory, Compliance, and Privacy Due Diligence — Finding Your Goldilocks Zone
Read More
Article | July 25, 2023
FDA's Proposed Compliance "Revamp": What Does It Mean for the Agency, Industry, and Consumers?
Read More
Article | July 17, 2023
FDA Publishes First Draft Guidance for Clinical Trials with Psychedelic Drugs
Read More
Article | June 21, 2023
Beyond Paperwork: Assessing the Effectiveness of a Compliance Program
Read More
Article | June 14, 2023
New WA Privacy Law ‘Turns The Beat Around’ on Drug and Device Makers
Read More